What's new

29 Nov 2019

MASK-air app Winners of the 2nd Edition of Value Added Medicines Award

Value added medicines conference urges paradigm shift across the healthcare access and regulatory landscape

Value added medicines deliver sustainable and continuous innovation with existing molecules and enhance patients’ well-being.
The 3rd Value Added Medicines Conference brought together thought leaders to discuss the future of digital delivery and the regulatory and market access framework for value added medicines, to help tackle chronic diseases and an ageing population.
According to IQVIA, value added medicines have grown 1% in volume in the EU over the last year, and many more initiatives are needed for improving patients’ access to value added medicines.

During the conference, a multi-stakeholder exchange of ideas identified clear next steps to improve patients’ access to value added medicines:

 

• Timely approval of value added medicines via streamlined scientific advice processes, fit-for-purpose trial designs and agreed approval pathways with tailor-made incentives for innovation.

• “Next generation guidelines” advised by physicians here.

• A pragmatic value framework that enables access to value added medicines and considers the specific benefits of value added medicines.

• The contribution of digital value added medicines in changing the paradigm of disease management and benefiting patients, healthcare professionals and healthcare systems.

 

 

 

 

 

 

The Value Added Medicines sector group instituted two awards for projects that bring value added solutions to patients.

The winners of the 2019 awards were:

Winner category “Scientific research/projects led by academics/healthcare professionals/developers that aim to improve existing treatment adherence and/or convenience and/or patients’ preferences and/or demonstrate relevant value added benefits for patients.”
Project “MASK digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice and value-added medicines”,

Prof Dr Jean Bousquet

 

You are Project leader

You are project manager

Health innovation and personalized medicine are our expertise. We may help you to accelerate the development of biomarkers, connected medical devices or digital healthcare solutions by bringing the right expertise at the right time.

Learn more

You are volonteer

You are volonteer

You are a citizen, a patient, a care provider, or a healthcare professional, and you wish to reshape with us the future of healthcare? KYomed INNOV welcomes and value you as full partner in the health innovation process. Learn more about us and join our community.

Learn more

Loading